Export your current network:
... as a bitmap image:
file format is 'PNG': portable network graphic
... as a high-resolution bitmap:
same PNG format, but at higher resolution
... as a vector graphic:
SVG: scalable vector graphic - can be opened and edited in Illustrator, CorelDraw, Dia, etc
... as short tabular text output:
TSV: tab separated values - can be opened in Excel and Cytoscape (lists only one-way edges: A-B)
... as tabular text output:
TSV: tab separated values - can be opened in Excel (lists reciprocal edges: A-B,B-A)
... as an XML summary:
structured XML interaction data, according to the 'PSI-MI' data standard
... protein node degrees:
node degree of proteins in your network (given the current score cut-off)
... network coordinates:
a flat-file format describing the coordinates and colors of nodes in the network
... protein sequences:
MFA: multi-fasta format - containing the aminoacid sequences in the network
... protein annotations:
a tab-delimited file describing the names, domains and descriptions of proteins in your network
... functional annotations:
a tab-delimited file containing all known functional terms of protiens in your network
Browse interactions in tabular form:
node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
BAK1 | BBC3 | ENSCAFP00000001448 | ENSCAFP00000054385 | BCL2 antagonist/killer 1. | Uncharacterized protein. | 0.778 |
BAK1 | BCL2 | ENSCAFP00000001448 | ENSCAFP00000000102 | BCL2 antagonist/killer 1. | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | 0.819 |
BAK1 | BCL2A1 | ENSCAFP00000001448 | ENSCAFP00000053072 | BCL2 antagonist/killer 1. | BCL2 related protein A1. | 0.935 |
BAK1 | BCL2L1 | ENSCAFP00000001448 | ENSCAFP00000010478 | BCL2 antagonist/killer 1. | BCL2 like 1. | 0.996 |
BAK1 | BID | ENSCAFP00000001448 | ENSCAFP00000052515 | BCL2 antagonist/killer 1. | BH3 interacting domain death agonist. | 0.990 |
BAK1 | BMF | ENSCAFP00000001448 | ENSCAFP00000066681 | BCL2 antagonist/killer 1. | Bcl2 modifying factor. | 0.629 |
BAK1 | MCL1 | ENSCAFP00000001448 | ENSCAFP00000017738 | BCL2 antagonist/killer 1. | Induced myeloid leukemia cell differentiation protein Mcl-1 homolog; Involved in the regulation of apoptosis versus cell survival, and in the maintenance of viability but not of proliferation. Mediates its effects by interactions with a number of other regulators of apoptosis (By similarity); Belongs to the Bcl-2 family. | 0.897 |
BAK1 | PMAIP1 | ENSCAFP00000001448 | ENSCAFP00000032282 | BCL2 antagonist/killer 1. | Phorbol-12-myristate-13-acetate-induced protein 1; Promotes activation of caspases and apoptosis. Promotes mitochondrial membrane changes and efflux of apoptogenic proteins from the mitochondria. Contributes to p53/TP53-dependent apoptosis after radiation exposure. Promotes proteasomal degradation of MCL1. Competes with BAK1 and with BIM/BCL2L11 for binding to MCL1; can displace BAK1 and BIM/BCL2L11 from their binding sites (By similarity). Belongs to the PMAIP1 family. | 0.661 |
BAK1 | TP53 | ENSCAFP00000001448 | ENSCAFP00000064590 | BCL2 antagonist/killer 1. | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its intera [...] | 0.976 |
BBC3 | BAK1 | ENSCAFP00000054385 | ENSCAFP00000001448 | Uncharacterized protein. | BCL2 antagonist/killer 1. | 0.778 |
BBC3 | BCL2 | ENSCAFP00000054385 | ENSCAFP00000000102 | Uncharacterized protein. | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | 0.933 |
BBC3 | BCL2A1 | ENSCAFP00000054385 | ENSCAFP00000053072 | Uncharacterized protein. | BCL2 related protein A1. | 0.809 |
BBC3 | BCL2L1 | ENSCAFP00000054385 | ENSCAFP00000010478 | Uncharacterized protein. | BCL2 like 1. | 0.986 |
BBC3 | BID | ENSCAFP00000054385 | ENSCAFP00000052515 | Uncharacterized protein. | BH3 interacting domain death agonist. | 0.934 |
BBC3 | BMF | ENSCAFP00000054385 | ENSCAFP00000066681 | Uncharacterized protein. | Bcl2 modifying factor. | 0.603 |
BBC3 | BOK | ENSCAFP00000054385 | ENSCAFP00000036994 | Uncharacterized protein. | Uncharacterized protein. | 0.607 |
BBC3 | MCL1 | ENSCAFP00000054385 | ENSCAFP00000017738 | Uncharacterized protein. | Induced myeloid leukemia cell differentiation protein Mcl-1 homolog; Involved in the regulation of apoptosis versus cell survival, and in the maintenance of viability but not of proliferation. Mediates its effects by interactions with a number of other regulators of apoptosis (By similarity); Belongs to the Bcl-2 family. | 0.949 |
BBC3 | PMAIP1 | ENSCAFP00000054385 | ENSCAFP00000032282 | Uncharacterized protein. | Phorbol-12-myristate-13-acetate-induced protein 1; Promotes activation of caspases and apoptosis. Promotes mitochondrial membrane changes and efflux of apoptogenic proteins from the mitochondria. Contributes to p53/TP53-dependent apoptosis after radiation exposure. Promotes proteasomal degradation of MCL1. Competes with BAK1 and with BIM/BCL2L11 for binding to MCL1; can displace BAK1 and BIM/BCL2L11 from their binding sites (By similarity). Belongs to the PMAIP1 family. | 0.979 |
BBC3 | TP53 | ENSCAFP00000054385 | ENSCAFP00000064590 | Uncharacterized protein. | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its intera [...] | 0.714 |
BCL2 | BAK1 | ENSCAFP00000000102 | ENSCAFP00000001448 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | BCL2 antagonist/killer 1. | 0.819 |
page 1 of 5